SMSPHARMA

SMS Pharmaceuticals Share Price

₹262.55 -3.85 (-1.45%)

21 May, 2025 03:29

SIP TrendupStart SIP in SMSPHARMA

Start SIP

Performance

  • Low
  • ₹260
  • High
  • ₹271
  • 52 Week Low
  • ₹175
  • 52 Week High
  • ₹398
  • Open Price₹269
  • Previous Close₹266
  • Volume140,094

Investment Returns

  • Over 1 Month + 20.96%
  • Over 3 Month + 37.48%
  • Over 6 Month + 4.83%
  • Over 1 Year + 26.53%
SIP Lightning

Smart Investing Starts Here Start SIP with SMS Pharmaceuticals for Steady Growth!

Invest Now

SMS Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 35.2
  • PEG Ratio
  • 0.5
  • Market Cap Cr
  • 2,328
  • P/B Ratio
  • 4.1
  • Average True Range
  • 10.66
  • EPS
  • 7.46
  • Dividend Yield
  • 0.2
  • MACD Signal
  • 10.06
  • RSI
  • 68.43
  • MFI
  • 67.23

SMS Pharmaceuticals Financials

SMS Pharmaceuticals Technicals

EMA & SMA

Current Price
₹262.55
-3.85 (-1.45%)
pointer
  • stock-down_img
  • Bearish Moving Average 0
  • stock-up_img
  • Bullish Moving Average 16
  • 20 Day
  • ₹245.15
  • 50 Day
  • ₹231.00
  • 100 Day
  • ₹230.85
  • 200 Day
  • ₹233.25

Resistance and Support

264.66 Pivot Speed
  • R3 279.83
  • R2 275.48
  • R1 269.01
  • S1 258.19
  • S2 253.84
  • S3 247.37

What's your outlook on SMS Pharmaceuticals?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

SMS Pharmaceuticals Ltd. is a prominent Indian pharmaceutical company specializing in the manufacturing of active pharmaceutical ingredients (APIs) and intermediates. The company focuses on quality, innovation, and regulatory compliance, catering to both domestic and international markets in the healthcare sector.

Sms Pharmaceuticals has an operating revenue of Rs. 780.35 Cr. on a trailing 12-month basis. An annual revenue growth of 35% is outstanding, Pre-tax margin of 9% is okay, ROE of 9% is fair but needs improvement. The company has a reasonable debt to equity of 23%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 200DMA and around 20% above its 50DMA. It needs to stay above the 200DMA levels to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 52 which is a POOR score indicating inconsistency in earnings, a RS Rating of 81 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 76 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

SMS Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-02-12 Quarterly Results & Others To consider other business matters. per share(30%)Final Dividend
2024-11-08 Quarterly Results
2024-08-05 Quarterly Results
2024-05-29 Audited Results & Final Dividend
2024-02-08 Quarterly Results & Preferential issue
Date Purpose Remarks
2024-09-23 FINAL Rs.0.40 per share(40%)Final Dividend
2023-09-22 FINAL Rs.0.30 per share(30%)Final Dividend
2022-09-23 FINAL Rs.0.30 per share(30%)Final Dividend
View More

SMS Pharmaceuticals F&O

SMS Pharmaceuticals Shareholding Pattern

66.26%
2.43%
0.08%
26.35%
4.88%

About SMS Pharmaceuticals

  • NSE Symbol
  • SMSPHARMA
  • BSE Symbol
  • 532815
  • Chairman & Managing Director
  • Mr. Ramesh Babu Potluri
  • ISIN
  • INE812G01025

Similar Stocks to SMS Pharmaceuticals

SMS Pharmaceuticals FAQs

SMS Pharmaceuticals share price is ₹262 As on 21 May, 2025 | 03:15

The Market Cap of SMS Pharmaceuticals is ₹2327.6 Cr As on 21 May, 2025 | 03:15

The P/E ratio of SMS Pharmaceuticals is 35.2 As on 21 May, 2025 | 03:15

The PB ratio of SMS Pharmaceuticals is 4.1 As on 21 May, 2025 | 03:15

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23